BioMerieux SA (BMXMF)
101.91
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
BioMerieux Price: 101.91 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 101.91 | 101.91 | 101.91 | 101.91 | 0.000 |
| May 16, 2024 | 101.91 | 101.91 | 101.91 | 101.91 | 60.00 |
| May 15, 2024 | 106.45 | 106.45 | 106.45 | 106.45 | 0.000 |
| May 14, 2024 | 106.45 | 106.45 | 106.45 | 106.45 | 0.000 |
| May 13, 2024 | 106.45 | 106.45 | 106.45 | 106.45 | 0.000 |
| May 10, 2024 | 106.45 | 106.45 | 106.45 | 106.45 | 0.000 |
| May 09, 2024 | 106.45 | 106.45 | 106.45 | 106.45 | 0.000 |
| May 08, 2024 | 106.45 | 106.45 | 106.45 | 106.45 | 100.00 |
| May 07, 2024 | 106.20 | 106.20 | 106.20 | 106.20 | 0.000 |
| May 06, 2024 | 106.20 | 106.20 | 106.20 | 106.20 | 0.000 |
| May 03, 2024 | 106.20 | 106.20 | 106.20 | 106.20 | 50.00 |
| May 02, 2024 | 103.15 | 103.15 | 103.15 | 103.15 | 0.000 |
| May 01, 2024 | 109.95 | 109.95 | 103.15 | 103.15 | 828.00 |
| Apr 30, 2024 | 105.67 | 105.67 | 105.67 | 105.67 | 0.000 |
| Apr 29, 2024 | 105.67 | 105.67 | 105.67 | 105.67 | 0.000 |
| Apr 26, 2024 | 105.67 | 105.67 | 105.67 | 105.67 | 56.00 |
| Apr 25, 2024 | 105.69 | 105.69 | 105.69 | 105.69 | 0.000 |
| Apr 24, 2024 | 105.69 | 105.69 | 105.69 | 105.69 | 0.000 |
| Apr 23, 2024 | 105.69 | 105.69 | 105.69 | 105.69 | 125.00 |
| Apr 22, 2024 | 105.00 | 105.00 | 105.00 | 105.00 | 0.000 |
| Apr 19, 2024 | 105.00 | 105.00 | 105.00 | 105.00 | 150.00 |
| Apr 18, 2024 | 105.56 | 105.56 | 103.17 | 103.17 | 221.00 |
| Apr 17, 2024 | 111.00 | 111.00 | 111.00 | 111.00 | 0.000 |
| Apr 16, 2024 | 111.00 | 111.00 | 111.00 | 111.00 | 45.00 |
| Apr 15, 2024 | 111.60 | 111.60 | 111.60 | 111.60 | 100.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
75.70
Minimum
Sep 09 2019
168.85
Maximum
Oct 12 2020
110.84
Average
106.50
Median
Jul 28 2022
Price Benchmarks
| DBV Technologies SA | 0.5832 |
| Cellectis SA | 3.00 |
| PHAXIAM Therapeutics SA (DELISTED) | 3.10 |
| Genfit SA | 3.79 |
| Innate Pharma SA | 2.710 |
Price Related Metrics
| PE Ratio | 31.26 |
| PS Ratio | 3.041 |
| Price to Book Value | 2.903 |
| Price to Free Cash Flow | 105.00 |
| Earnings Yield | 3.20% |
| Market Cap | 12.04B |
| Operating PE Ratio | 19.67 |
| Normalized PE Ratio | 24.21 |